Hormones and venous thromboembolism among postmenopausal women.

about

Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse.Oral Contraceptives and HRT Risk of Thrombosis.No sweat: managing menopausal symptoms at work.

P2860

Q33653054-91E96EBD-DA57-4B0A-9B36-18E25ACB51C7 Q39066094-38FE7770-35C7-41EF-A83D-1B4D1DFC5506 Q47320076-8593C22C-7FAD-40F7-A37C-76B592AD0325

P2860

Hormones and venous thromboembolism among postmenopausal women.

Item

http://www.wikidata.org/entity/Q38249888

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Hormones and venous thromboembolism among postmenopausal women.

@en

type

Item

label

Hormones and venous thromboembolism among postmenopausal women.

@en

prefLabel

Hormones and venous thromboembolism among postmenopausal women.

@en

P1476

Hormones and venous thromboembolism among postmenopausal women.

@en

P2093

P-Y Scarabin

http://www.w3.org/2001/XMLSchema#string

P2860

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

EMAS position statement: Managing menopausal women with a personal or family history of VTE.

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

Current knowledge on the genetics of incident venous thrombosis.

P304

34-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3109/13697137.2014.956717

http://www.w3.org/2001/XMLSchema#string

P478

17 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25223916

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

Hormones and venous thromboembolism among postmenopausal women.

about

P2860

P2860

Hormones and venous thromboembolism among postmenopausal women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921